TERUMO CORPORATION(4543) Summary
4543
TSE Prime
TERUMO CORPORATION
Result
ー
2,500.5
JPY
-127.0
(-4.83%)
Nov 6, 3:30 pm JST
15.83
USD
Nov 6, 1:30 am EST
PER
30.7
PBR
2.22
Yield
1.44%
Margin Trading Ratio
3.34
PTS
outside of trading hours
ー
ー
Stock Price
Nov 6, 2026
Opening
Nov 6, 9:00 am
2,597.0
JPY
16.48
USD
Previous Close
Nov 5
2,627.5
JPY
16.64
USD
High
Nov 6, 9:49 am
2,627.0
JPY
16.66
USD
Low
Nov 6, 3:14 pm
2,480.0
JPY
15.71
USD
Volume
8,714,500
Trading Value
0.02T
JPY
0.14B
USD
VWAP
2542.79
JPY
16.1
USD
Minimum Trading Value
250,050
JPY
1,583
USD
Market Capitalization
3.70T
JPY
0.02T
USD
Number of Trades
21,515
Opening
ー
ー
JPY
Previous Close
Nov 6
2,488.4
JPY
High
ー
ー
JPY
Low
ー
ー
JPY
Volume
ー
Trading Value
ー
JPY
VWAP
ー
JPY
Minimum Trading Value
ー
Market Capitalization
ー
Number of Trades
ー
PTS Stock Price
Liquidity & Number of Trades
As of Nov 6, 2026
Liquidity
Liquidity Grade
| Liquidity | Number Of Trades | Distribution |
|---|---|---|
| High | Over 1,000 | 13.9% |
| Slightly-High | 400 to 1,000 | 18.5% |
| Mid | 50 to 400 | 39.0% |
| Slightly-Low | 10 to 50 | 17.6% |
| Low | Less than 10 | 11.0% |
High
1-Year Average
8,315
1-Year High
Nov 6, 2026
21,515
Margin Trading
| Date | Short Interest | Long Margin Positions | Ratio |
|---|---|---|---|
| Oct 30, 2026 | 127,100 | 424,800 | 3.34 |
| Oct 23, 2026 | 131,700 | 496,600 | 3.77 |
| Oct 16, 2026 | 128,800 | 515,300 | 4.00 |
| Oct 9, 2026 | 128,100 | 663,400 | 5.18 |
| Oct 2, 2026 | 117,200 | 815,700 | 6.96 |
Similar Stocks
Company Profile
TERUMO CORPORATION is a leading manufacturer of medical devices, with a strong presence in the cardiovascular field. The company holds a high global market share in catheters and heart-lung machines.
Sector
Website
TERUMO CORPORATION is a major medical device manufacturer with its business divided into three segments: "Cardiac and Vascular Company," "Medical Care Solutions Company," and "Blood and Cell Technologies Company." The group consists of numerous consolidated subsidiaries and equity-method affiliates, operating globally with an overseas sales ratio approaching 80%. The company offers a wide range of products across various business fields, with a particular strength in cardiovascular care, providing comprehensive solutions to meet the needs of medical professionals.